Androgenetic Alopecia, Telogen Effluvium
Conditions
Brief summary
The goal of this observational study is to learn about the effects of anti-hair loss shampoo in subjects over the age of 18 who use shampoo to treat their hair loss caused by telogen effluvium (TE) and androgenetic alopecia (AGA). The main question it aims to answer is: • Does a shampoo use help to reduce the visible signs of hair loss related to TE and AGA? Subjects will use the shampoo for 3 months and visit the clinic for the visits established by the protocol.
Interventions
OTHERanti-hair loss shampoo
anti-hair loss shampoo use for 3 months
Sponsors
Lacer S.A.
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Sex: Both (50% women; 50% men). * Age: 18-65 years. * Subjects with hair loss due to telogen effluvium or mild or incipient androgenic alopecia, in an 80/20 ratio. * Degree of androgenic alopecia: Ludwig scale score I-II for women and Hamilton-Norwood scale score III-II for men. * Telogen effluvium: Combing test. * Subjects with all hair types (oily, combination, sensitive, etc.). * Subjects with all scalp types (normal, sensitive, etc.). * Agree to participate voluntarily in the study and provide written informed consent. * Adequate level of understanding of the clinical study. * Good health (physical and mental). * Availability to attend visits to the research centres. * No application of any product to the experimental area on the first day of the trial.
Exclusion criteria
* Individuals under 18 years of age. * Pregnant or breastfeeding women. * Injuries or infection in the test area. * History of allergies to cosmetic products. * Known allergies to product components. * Sensitivity to any product component. * Patients who have undergone recent surgery or treatments in the study area. * Cancer patients. * Volunteers currently taking antibiotics, antihistamines, corticosteroids, beta-blockers, retinoids, azelaic acid, or acne therapies, or whose treatment ended within 15 days prior to the start of the study. Participation in another clinical study. * Use of or having used cosmetic products and/or oral or topical treatments for hair loss for at least 6 months. * Hair cutting or dyeing during the study. * Health problems, to be assessed by the specialist, that may compromise adherence to the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair lenght and thickness | From baseline to the end of use at 3 months. |
Secondary
| Measure | Time frame |
|---|---|
| Change in hair lenght and thickness at 1 month | Baseline and 1 month of use |
Countries
Spain
Outcome results
None listed